No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
ABBV240719C160000
- 11.40
- +2.02+21.54%
15min DelayClose Jul 12 16:00 ET
11.40High10.19Low
10.19Open9.38Pre Close6.49K Volume1.12K Open Interest160.00Strike Price7.25MTurnover0.00%IV0.66%PremiumJul 19, 2024Expiry Date10.28Intrinsic Value100Multiplier4DDays to Expiry1.12Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma17.07Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Intraday
- 5D
- Daily
News
Morgan Stanley Sees $180B Patent Cliff, $380B Deal Capacity Fueling Biopharma M&A
These Are the Weight Loss Drug Stocks With the Most Upside - SA Sentiment Survey
AbbVie Earnings Preview: What to Expect
Express News | AbbVie Submits Applications To FDA And EMA For New Indication Of Upadacitinib (RINVOQ) For Treatment Of Giant Cell Arteritis; Supported By Phase 3 SELECT-GCA Study Showing Sustained Remission And Consistent Safety Profile
Express News | Abbvie Submits Regulatory Applications to FDA and EMA for Upadacitinib (Rinvoq®) in Giant Cell Arteritis
Dividend Roundup: Procter & Gamble, Costco, CVS Health, Colgate-Palmolive, and More
Comments
$Genmab(GMAB.US$ $AbbVie(ABBV.US$
EPKINLY (Epcoritamab) Now Approved for Patients w/ Follicular Lymphoma (FL)
» Positive results in Ph1/2 EPCORE® NHL-1 study for R/R FL
» Offers off-the-shelf T-cell therapy
» First-of-its-kind antibody for both R/R FL & DLBCL after prior treatments (2+ lines)
EPKINLY (Epcoritamab) Now Approved for Patients w/ Follicular Lymphoma (FL)
» Positive results in Ph1/2 EPCORE® NHL-1 study for R/R FL
» Offers off-the-shelf T-cell therapy
» First-of-its-kind antibody for both R/R FL & DLBCL after prior treatments (2+ lines)
3
$Chevron(CVX.US$
One of the U.S.’s largest energy corporations, Chevron Corporation (NYSE:CVX) specializes in oil, gas and renewable fuels. The company has upstream and downstream operations focused on the oil and gas industry. Oil companies are an interesting pick since the best ones are known for paying dividends, even in bad times.
Chevron has a 37-year history of increasing dividends and has consistently paid them since ...
One of the U.S.’s largest energy corporations, Chevron Corporation (NYSE:CVX) specializes in oil, gas and renewable fuels. The company has upstream and downstream operations focused on the oil and gas industry. Oil companies are an interesting pick since the best ones are known for paying dividends, even in bad times.
Chevron has a 37-year history of increasing dividends and has consistently paid them since ...
33
3
From YouTube
6
Interesting both for the (1) shift in the macro-trend to M&A (vs. Licensing) and (2) change in top spenders
$Merck & Co(MRK.US$ $Bristol-Myers Squibb(BMY.US$ $Johnson & Johnson(JNJ.US$ $Pfizer(PFE.US$ $Novo-Nordisk A/S(NVO.US$ $AbbVie(ABBV.US$
$Merck & Co(MRK.US$ $Bristol-Myers Squibb(BMY.US$ $Johnson & Johnson(JNJ.US$ $Pfizer(PFE.US$ $Novo-Nordisk A/S(NVO.US$ $AbbVie(ABBV.US$
10
1
Read more